• Publications
  • Influence
The metric properties of a novel non‐motor symptoms scale for Parkinson's disease: Results from an international pilot study
TLDR
NMSS can be used to assess the frequency and severity of NMS in PD patients across all stages in conjunction with the recently validated non‐motor questionnaire.
The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease
TLDR
A key role for NMS in the clinical frame of PD is supported and the need to address them specifically in clinical trials using dedicated scales is addressed.
International multicenter pilot study of the first comprehensive self‐completed nonmotor symptoms questionnaire for Parkinson's disease: The NMSQuest study
TLDR
An international pilot study assessing feasibility, validity, and acceptability of a nonmotor questionnaire (NMSQuest) found NMS were highly significantly more prevalent across all disease stages and the number of symptoms correlated significantly with advancing disease and duration of disease.
Validation of the freezing of gait questionnaire in patients with Parkinson's disease
TLDR
FOG‐Q was a reliable tool for the assessment of treatment intervention and was best correlated to items of the UPDRS relating to walking, general motor issues, and mobility.
A double-blind, delayed-start trial of rasagiline in Parkinson's disease.
TLDR
Early treatment with rasagiline at a dose of 1 mg per day provided benefits that were consistent with a possible disease-modifying effect, but early treatment with the two doses were associated with different outcomes, the study results must be interpreted with caution.
Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: The STRIDE‐PD study
TLDR
This work has suggested that combining L‐dopa with entacapone, an inhibitor of catechol‐O‐methyltransferase, to extend its elimination half‐life might reduce the risk of motor complications in patients with Parkinson's disease.
Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; Study using nonmotor symptoms questionnaire in 545 patients
TLDR
The results gathered from 545 patients using the definitive version of the NMSQuest are presented highlighting the prevalence of the wide range of NMS flagged in the N MSQuest from consecutive PD patients in an international setting.
The nondeclaration of nonmotor symptoms of Parkinson's disease to health care professionals: An international study using the nonmotor symptoms questionnaire
TLDR
The most frequently nondeclared symptoms of Parkinson's disease patients were delusions, daytime sleepiness, intense and vivid dreams, and dizziness, and in many, appropriate treatments for undeclared NMS were started only after these were recognised following completion of NMSQuest.
...
1
2
3
4
5
...